$0.68
arrow_drop_down2.71%Key Stats | |
---|---|
Open | $0.72 |
Prev. Close | $0.70 |
EPS | -1.35 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $43.29M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.65 | 0.72 |
52 Week Range | 0.57 | 1.79 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.35 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference
Passage Bio Announces Positive Feedback from FDA on - GlobeNewswire
Passage Bio (PASG) Loses -22.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
All You Need to Know About Passage Bio (PASG) Rating Upgrade to Buy
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights